AVTR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $15.34

Kapitalisasi Pasar $10.46B

P/E (TTM) -18.3

EPS (TTM) $-0.84

Pendapatan (TTM) $6.56B

ROE (TTM) -9.7%

D/E Utang/Ekuitas (MRQ) 0.7

Rentang 52M $7–$16

AVTR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Tentang Avantor, Inc. Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.

History

The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.

In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.

In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.

In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.

That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.

In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.

In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.

The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.

Controversies

On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”

Baca selengkapnya Tampilkan lebih sedikit

Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

sektorHealthcare industriLife Sciences Tools & Services karyawan13.500 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$6.55B

2017-12-31 → 2025-12-31

EPS$-0.78

2018-12-31 → 2025-12-31

Arus Kas Bebas$495M

2019-12-31 → 2025-12-31

Margin bersih-8.8%

2019-12-31 → 2025-12-31

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	AVTR	rata-rata 5T	Median Rekan	Kesimpulan
P/E (TTM)	-18.3rata-rata 5T ≈24.9	≈24.9	·	·
P/S	1.6rata-rata 5T ≈2.2	≈2.2	3.7	Kurang nilai
P/B	1.9rata-rata 5T ≈3.2	≈3.2	3.6	Kurang nilai
EV / EBITDA	-57.0rata-rata 5T ≈10.3	≈10.3	·	·
Price / FCF (Harga / FCF)	21.1rata-rata 5T ≈21.7	≈21.7	·	·
Price / Cash Flow (Harga / Arus Kas)	16.8rata-rata 5T ≈18.2	≈18.2	25.2	Kurang nilai
EV / Revenue (EV / Pendapatan)	2.1rata-rata 5T ≈2.9	≈2.9	·	·
EV / FCF	28.4rata-rata 5T ≈28.9	≈28.9	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	AVTR	rata-rata 5T	Median Rekan	Kesimpulan
Margin Kotor (TTM)	31.8%rata-rata 5T ≈33.7%	≈33.7%	54.2%	Lemah
Margin Operasi (TTM)	-4.6%rata-rata 5T ≈10.1%	≈10.1%	9.2%	Di bawah rata-rata
EBITDA Margin (Margin EBITDA)	-3.8%rata-rata 5T ≈10.1%	≈10.1%	8.3%	Lemah
Margin Sebelum Pajak (TTM)	-7.2%rata-rata 5T ≈6.7%	≈6.7%	5.9%	Di bawah rata-rata
Margin Laba Bersih (TTM)	-8.8%rata-rata 5T ≈4.8%	≈4.8%	2.4%	Sejajar
ROA (TTM)	-4.7%rata-rata 5T ≈2.7%	≈2.7%	-0.14%	Lemah
ROE (TTM)	-9.7%rata-rata 5T ≈7.6%	≈7.6%	-0.40%	Lemah
ROIC	-3.1%rata-rata 5T ≈5.1%	≈5.1%	1.1%	Lemah

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	AVTR	rata-rata 5T	Median Rekan	Kesimpulan
Utang / Ekuitas (MRQ)	0.7rata-rata 5T ≈1.1	≈1.1	0.7	Sejajar
Rasio Lancar (MRQ)	1.8rata-rata 5T ≈1.6	≈1.6	3.0	Likuiditas rendah
Quick Ratio (Rasio Cepat)	1.0rata-rata 5T ≈0.9	≈0.9	1.6	Di bawah rata-rata
Utang Jangka Panjang / Ekuitas (MRQ)	0.7rata-rata 5T ≈1.0	≈1.0	0.7	Sejajar

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	AVTR	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)	-3.4%rata-rata 5T ≈0.78%	≈0.78%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)	-4.5%rata-rata 5T ≈-1.4%	≈-1.4%	·	·
Revenue CAGR 5Y (CAGR Pendapatan 5T)	0.49%	·	·	·
EPS YoY	121.3%rata-rata 5T ≈232.8%	≈232.8%	·	·
Net Income YoY (Laba Bersih YoY)	121.6%rata-rata 5T ≈119.8%	≈119.8%	·	·
EPS CAGR 3Y (CAGR EPS 3T)	7.0%	·	·	·
Net Income CAGR 3Y (CAGR Laba Bersih 3T)	7.5%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	AVTR	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$-0.78rata-rata 5T ≈$0.52	≈$0.52	·	·
Revenue / Share (Pendapatan / Saham)	$9.63rata-rata 5T ≈$10.64	≈$10.64	·	·
Cash Flow / Share (Arus Kas / Saham)	$0.92rata-rata 5T ≈$1.25	≈$1.25	·	·
Cash / Share (Kas / Saham)	$0.54rata-rata 5T ≈$0.47	≈$0.47	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	AVTR	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)	0.5rata-rata 5T ≈0.6	≈0.6	0.5	Sejajar
Inventory Turnover (Perputaran Persediaan)	5.7rata-rata 5T ≈5.7	≈5.7	2.5	Tingkat teratas
Receivables Turnover (Perputaran Piutang)	6.2rata-rata 5T ≈6.2	≈6.2	5.7	Tingkat teratas
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)	≈$485.3K	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 0.49%

Laporan Berikutnya Okt 27, 2026

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Jul 30, 2026	$0.21	$0.19	8.6%
31 Maret 2026		$0.17	$0.16	6.2%
31 Des. 2025		$0.22	$0.22	-0.36%
30 Sep. 2025		$0.22	$0.23	-4.0%
30 Juni 2025		$0.24	$0.25	-5.1%
31 Maret 2025		$0.23	$0.24	-2.4%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 16

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	$5.86B	$1.25B
Cost of Revenue	$4.41B	$4.50B	$4.60B	$4.91B	$4.88B	$4.31B	$4.12B	$4.04B	$815M
Gross Profit	$2.14B	$2.28B	$2.36B	$2.60B	$2.50B	$2.08B	$1.92B	$1.82B	$433M
SG&A Expense	$1.60B	$1.64B	$1.51B	$1.47B	$1.53B	$1.37B	$1.37B	$1.41B	$450M
Operating Income	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	$414M	$-210M
Interest Expense	·	·	$285M	$266M	$217M	$308M	$440M	$524M	$201M
Interest Income	$42M	$75M	$65M	$16M	$2M	·	·	·	·
Other Non-op	$-21M	$-1M	$6M	$-800.0K	$11M	$10M	$2M	$-4M	$8M
Pretax Income	$-441M	$854M	$410M	$851M	$753M	$62M	$41M	$-114M	$-460M
Income Tax	$89M	$142M	$89M	$165M	$180M	$-54M	$3M	$-27M	$-315M
Net Income	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	$-87M	$-113M
EPS (Basic)	$-0.78	$1.05	$0.48	$1.02	$0.86	$0.09	$-0.84	$-2.69	·
EPS (Diluted)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	$-2.69	·
Shares (Basic)	680,600,000	679,600,000	675,600,000	650,900,000	590,500,000	576,300,000	401,200,000	132,700,000	·
Shares (Diluted)	680,600,000	681,900,000	678,400,000	679,400,000	599,600,000	583,400,000	401,200,000	132,700,000	·
EBITDA	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	·	·

Neraca 26

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$365M	$262M	$263M	$373M	$302M	$287M	$187M	$185M	·
Receivables	$1.07B	$1.03B	$1.15B	$1.22B	$1.22B	$1.11B	$989M	$931M	·
Inventory	$818M	$732M	$828M	$914M	$872M	$740M	$711M	$671M	·
Other Current Assets	$193M	$119M	$144M	$153M	$81M	$91M	$135M	$113M	·
Current Assets	$2.45B	$2.15B	$2.38B	$2.66B	$2.48B	$2.23B	$2.02B	$1.90B	·
PP&E (Net)	$767M	$708M	$738M	$727M	$706M	$550M	$557M	$599M	·
PP&E (Gross)	$1.51B	$1.34B	$1.35B	$1.25B	$1.15B	$938M	$865M	$824M	·
Accum. Depreciation	$745M	$630M	$617M	$518M	$445M	$388M	$308M	$226M	·
Goodwill	$4.99B	$5.54B	$5.72B	$5.65B	$5.34B	$2.86B	$2.77B	$2.78B	$2.85B
Intangibles	$3.10B	$3.27B	$3.68B	$4.04B	$5.05B	$3.96B	$4.13B	$4.47B	·
Other Non-current Assets	$396M	$360M	$358M	$294M	$233M	$217M	$205M	$63M	·
Total Assets	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Accounts Payable	$742M	$663M	$626M	$758M	$755M	$679M	$560M	$557M	·
Current Liabilities	$1.38B	$2.01B	$1.48B	$1.66B	$1.45B	$1.24B	$1.07B	$1.10B	·
Capital Leases	$152M	$143M	$88M	$87M	$79M	·	$107M	·	·
Deferred Tax	$557M	$557M	$613M	$731M	$913M	$724M	$785M	$908M	·
Other Non-current Liabilities	$378M	$358M	$350M	$295M	$358M	$398M	$428M	$318M	·
Total Liabilities	$6.23B	$6.16B	$7.72B	$8.61B	$9.70B	$7.23B	$7.31B	$9.10B	·
Long-term Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	$6.92B	·
Total Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	·	·
Retained Earnings	$1.67B	$2.20B	$1.49B	$1.17B	$484M	$-89M	$-204M	$-238M	·
Treasury Stock	$76M	$0	·	·	·	·	·	·	·
AOCI	$-17M	$-184M	$-69M	$-100M	$-43M	$22M	$-86M	$-66M	$26M
Stockholders' Equity	$5.57B	$5.96B	$5.25B	$4.86B	$4.20B	$2.67B	$2.46B	$-3.05B	$-2.62B
Liabilities + Equity	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Shares Outstanding	682,000,000	680,800,000	676,600,000	674,300,000	609,700,000	580,100,000	572,800,000	132,800,000	·

Arus Kas 18

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$410M	$406M	$402M	$406M	$379M	$395M	$399M	$405M	$99M
Stock-based Comp	$46M	$47M	$40M	$46M	$51M	$44M	$68M	$18M	$48M
Deferred Tax	$8M	$-47M	$-172M	$-69M	$-18M	$-88M	$-107M	$-104M	$-431M
Amort. of Intangibles	$301M	$300M	$308M	$318M	$291M	$308M	$312M	$321M	$65M
Restructuring	$30M	$83M	$26M	$4M	$5M	$12M	$24M	$81M	$30M
Operating Cash Flow	$624M	$841M	$870M	$844M	$954M	$930M	$354M	$200M	$-168M
CapEx	$129M	$149M	$146M	$133M	$111M	$62M	$52M	$38M	$25M
Investing Cash Flow	$-130M	$439M	$-144M	$-110M	$-4.12B	$-59M	$-42M	$-23M	$-6.68B
Debt Issued	$1.11B	$0	$0	$327M	$2.83B	$3.94B	$1M	$36M	$9.25B
Net Debt Issued	$-319M	$-1.34B	$-846M	$-620M	$2.30B	$-423M	$-1.88B	·	·
Stock Issued	·	·	$0	$0	$967M	$0	$4.24B	·	·
Stock Repurchased	$75M	$0	$0	·	·	·	·	·	·
Net Stock Activity	$-75M	·	$0	$0	$967M	·	·	·	·
Financing Cash Flow	$-409M	$-1.28B	$-844M	$-649M	$3.22B	$-783M	$-308M	$-170M	$6.96B
Net Change in Cash	$104M	$-23M	$-109M	$70M	$38M	$100M	$2M	$-800.0K	$122M
Taxes Paid	$145M	$248M	$224M	$257M	$145M	$43M	$112M	$66M	$32M
Free Cash Flow	$495M	$692M	$724M	$710M	$842M	$868M	$302M	·	·
Levered FCF	·	·	$501M	$496M	$677M	$292M	$-107M	·	·

Profitabilitas 8

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin	32.6%	33.6%	33.9%	34.6%	33.9%	32.5%	31.8%	·	·
Operating Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
Net Margin	-8.1%	10.5%	4.6%	9.1%	7.8%	1.8%	0.63%	·	·
Pretax Margin	-6.7%	12.6%	5.9%	11.3%	10.2%	0.97%	0.67%	·	·
EBITDA Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
ROA	-4.4%	5.7%	2.4%	5.0%	4.8%	1.2%	0.38%	·	·
ROE	-8.9%	12.4%	6.2%	14.5%	13.8%	4.5%	1.6%	·	·
ROIC	-3.1%	9.0%	5.1%	8.2%	6.6%	17.5%	6.8%	·	·

Likuiditas & Solvabilitas 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	1.8	1.1	1.6	1.6	1.7	1.8	1.9	·	·
Quick Ratio	1.0	0.6	1.0	1.0	1.1	1.1	1.1	·	·
Debt / Equity	0.7	0.7	1.1	1.3	1.7	1.8	2.1	·	·
LT Debt / Equity	0.7	0.5	1.0	1.2	1.7	1.8	2.0	·	·
Interest Coverage	·	·	2.4	4.3	4.5	2.3	1.3	·	·

Efisiensi 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.5	0.5	0.5	0.5	0.6	0.6	0.6	·	·
Inventory Turnover	5.7	5.8	5.3	5.5	6.1	5.9	6.0	·	·
Receivables Turnover	6.2	6.2	5.9	6.2	6.3	6.1	6.3	·	·

Per Saham 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$8.16	$8.75	$7.76	$7.20	$6.88	$4.61	$4.30	·	·
Revenue / Share	$9.63	$9.95	$10.27	$11.06	$12.32	$10.96	·	·	·
Cash Flow / Share	$0.92	$1.23	$1.28	$1.24	$1.59	$1.59	·	·	·
Cash / Share	$0.54	$0.38	$0.39	$0.55	$0.49	$0.49	$0.33	·	·
EPS (TTM)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	·	·

Tingkat Pertumbuhan 7

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-3.4%	-2.6%	-7.3%	1.7%	15.5%	·	·	·	·
Revenue CAGR 3Y	-4.5%	-2.8%	2.9%	·	·	·	·	·	·
Revenue CAGR 5Y	0.49%	·	·	·	·	·	·	·	·
EPS YoY	·	121.3%	-53.5%	18.8%	844.4%	·	·	·	·
EPS CAGR 3Y	·	7.0%	73.5%	·	·	·	·	·	·
Net Income YoY	·	121.6%	-53.2%	19.9%	391.1%	·	·	·	·
Net Income CAGR 3Y	·	7.5%	40.2%	·	·	·	·	·	·

Valuasi (TTM) 13

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	·	·
Net Income TTM	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	·	·
Market Cap	$7.82B	$14.34B	$15.45B	$14.22B	$25.69B	$16.33B	$10.40B	·	·
Enterprise Value	$11.40B	$18.14B	$20.72B	$20.14B	$32.41B	$20.94B	$15.33B	·	·
P/E	-14.7	20.3	48.6	20.9	49.6	312.8	-21.6	·	·
P/S	1.2	2.1	2.2	1.9	3.5	2.6	1.7	·	·
P/B	1.4	2.4	2.9	2.9	6.1	6.1	4.2	·	·
P / Cash Flow	12.5	17.1	17.8	16.9	26.9	17.6	29.4	·	·
P / FCF	15.8	20.7	21.3	20.0	30.5	18.8	34.4	·	·
EV / EBITDA	-46.3	16.7	29.8	17.8	33.3	29.6	27.8	·	·
EV / FCF	23.0	26.2	28.6	28.4	38.5	24.1	50.7	·	·
EV / Revenue	1.7	2.7	3.0	2.7	4.4	3.3	2.5	·	·
Earnings Yield	-6.8%	4.9%	2.1%	4.8%	2.0%	0.32%	-4.6%	·	·

Laporan Laba Rugi 16

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$1.69B	$1.58B	$1.66B	$1.62B	$1.68B	$1.58B	$1.69B	$1.71B	$1.70B	$1.68B	$1.72B	$1.72B	$1.74B	$1.78B	$1.79B	$1.86B
Cost of Revenue	$1.16B	$1.08B	$1.14B	$1.10B	$1.13B	$1.05B	$1.12B	$1.15B	$1.12B	$1.11B	$1.15B	$1.14B	$1.15B	$1.16B	$1.18B	$1.21B
Gross Profit	$537M	$501M	$524M	$526M	$554M	$535M	$563M	$564M	$582M	$570M	$570M	$579M	$590M	$625M	$614M	$651M
SG&A Expense	$415M	$401M	$392M	$390M	$425M	$388M	$371M	$440M	$406M	$424M	$387M	$368M	$358M	$394M	$363M	$375M
Operating Income	$122M	$100M	$126M	$-649M	$129M	$147M	$638M	$125M	$176M	$146M	$183M	$210M	$72M	$231M	$252M	$276M
Interest Expense	$39M	$43M	·	$44M	$43M	$42M	·	$49M	$61M	$64M	·	$72M	$73M	$74M	·	$67M
Interest Income	$10M	$10M	$11M	$12M	$11M	$8M	$12M	$27M	$18M	$18M	$18M	$17M	$16M	$14M	·	·
Other Non-op	$-600.0K	$-500.0K	$-1M	$4M	$-4M	$-20M	$-5M	$700.0K	$2M	$1M	$2M	$700.0K	$2M	$600.0K	$-6M	$3M
Pretax Income	$81M	$56M	$81M	$-690M	$82M	$86M	$584M	$74M	$115M	$81M	$120M	$136M	$-1M	$156M	$175M	$208M
Income Tax	$43M	$12M	$28M	$22M	$17M	$21M	$84M	$17M	$22M	$20M	$21M	$28M	$6M	$34M	$33M	$41M
Net Income	$38M	$43M	$52M	$-712M	$65M	$64M	$500M	$58M	$93M	$60M	$98M	$108M	$-7M	$122M	$142M	$167M
EPS (Basic)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.74	$0.08	$0.14	$0.09	$0.15	$0.16	$-0.01	$0.18	$0.20	$0.25
EPS (Diluted)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.73	$0.08	$0.14	$0.09	$0.14	$0.16	$-0.01	$0.18	$0.20	$0.25
Shares (Basic)	676,200,000	675,700,000	·	681,700,000	681,500,000	681,100,000	·	680,300,000	679,400,000	678,100,000	·	676,000,000	675,300,000	674,700,000	·	674,100,000
Shares (Diluted)	677,200,000	676,800,000	·	681,700,000	681,800,000	682,400,000	·	683,000,000	682,600,000	681,400,000	·	678,500,000	675,300,000	678,100,000	·	679,300,000
EBITDA	$122M	$100M	·	$-649M	$129M	$147M	·	$125M	$176M	$146M	·	$210M	$72M	$231M	·	$276M

Neraca 26

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$307M	$279M	$365M	$252M	$449M	$316M	$262M	$285M	$273M	$235M	·	$237M	$236M	$295M	·	$266M
Receivables	$1.14B	$1.10B	$1.07B	$1.08B	$1.15B	$1.10B	$1.03B	$1.09B	$1.13B	$1.13B	·	$1.15B	$1.22B	$1.28B	·	$1.23B
Inventory	$829M	$810M	$818M	$796M	$780M	$750M	$732M	$780M	$796M	$811M	·	$850M	$890M	$904M	·	$905M
Other Current Assets	$188M	$210M	$193M	$132M	$136M	$120M	$119M	$136M	$132M	$146M	·	$147M	$156M	$152M	·	$158M
Current Assets	$2.46B	$2.40B	$2.45B	$2.26B	$2.51B	$2.28B	$2.15B	$2.50B	$2.33B	$2.32B	·	$2.38B	$2.50B	$2.63B	·	$2.56B
PP&E (Net)	$772M	$766M	$767M	$762M	$759M	$736M	$708M	$723M	$754M	$740M	·	$698M	$698M	$736M	·	$698M
PP&E (Gross)	·	·	$1.51B	·	·	·	$1.34B	·	·	·	·	·	·	·	·	·
Accum. Depreciation	$787M	$766M	$745M	$724M	$700M	$663M	$630M	$621M	$657M	$635M	·	$580M	$565M	$541M	·	$489M
Goodwill	$4.94B	$4.95B	$4.99B	$4.98B	$5.76B	$5.61B	$5.54B	$5.67B	$5.66B	$5.67B	$5.72B	$5.64B	$5.69B	$5.68B	$5.65B	$5.51B
Intangibles	$2.92B	$3.01B	$3.10B	$3.17B	$3.26B	$3.24B	$3.27B	$3.43B	$3.49B	$3.57B	·	$3.70B	$3.80B	$3.98B	·	$4.01B
Other Non-current Assets	$412M	$442M	$396M	$406M	$391M	$368M	$360M	$420M	$368M	$368M	·	$289M	$277M	$272M	·	$245M
Total Assets	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Accounts Payable	$743M	$736M	$742M	$692M	$709M	$680M	$663M	$674M	$657M	$573M	·	$656M	$687M	$766M	·	$769M
Current Liabilities	$1.38B	$1.37B	$1.38B	$1.52B	$2.58B	$2.03B	$2.01B	$1.63B	$1.46B	$1.44B	·	$1.49B	$1.55B	$1.67B	·	$1.55B
Capital Leases	·	·	$152M	·	·	·	$143M	·	·	·	·	·	·	·	·	·
Deferred Tax	$540M	$550M	$557M	$548M	$536M	$550M	$557M	$547M	$575M	$601M	·	$649M	$663M	$696M	·	$728M
Other Non-current Liabilities	$383M	$377M	$378M	$403M	$391M	$365M	$358M	$419M	$362M	$361M	·	$271M	$269M	$300M	·	$334M
Total Liabilities	$5.97B	$6.07B	$6.23B	$6.11B	$6.49B	$6.23B	$6.16B	$7.29B	$7.26B	$7.43B	·	$7.70B	$8.05B	$8.40B	·	$8.52B
Long-term Debt	$3.70B	$3.82B	$3.95B	$3.86B	$4.24B	$4.11B	$4.06B	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Total Debt	$3.70B	$3.82B	·	$3.86B	$4.24B	$4.11B	·	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Retained Earnings	$1.75B	$1.72B	$1.67B	$1.62B	$2.33B	$2.27B	$2.20B	$1.70B	$1.64B	$1.55B	·	$1.39B	$1.28B	$1.29B	·	$1.03B
Treasury Stock	$76M	$76M	$76M	·	·	·	$0	·	·	·	·	·	·	·	·	·
AOCI	$-55M	$-44M	$-17M	$-24M	$-10M	$-118M	$-184M	$-74M	$-107M	$-97M	·	$-111M	$-72M	$-90M	$-100M	$-212M
Stockholders' Equity	$5.63B	$5.59B	$5.57B	$5.57B	$6.29B	$6.10B	$5.96B	$5.55B	$5.43B	$5.34B	$5.25B	$5.10B	$5.01B	$4.99B	$4.86B	$4.59B
Liabilities + Equity	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Shares Outstanding	·	682,900,000	682,000,000	681,900,000	681,600,000	681,500,000	680,800,000	680,600,000	679,600,000	679,200,000	·	676,300,000	675,700,000	675,100,000	·	674,200,000

Arus Kas 14

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$106M	$105M	$103M	$104M	$103M	$100M	$101M	$102M	$103M	$100M	$101M	$98M	$103M	$101M	$101M	$101M
Stock-based Comp	$15M	$9M	$11M	$7M	$16M	$12M	$11M	$12M	$11M	$13M	$9M	$10M	$9M	$13M	$10M	$12M
Deferred Tax	$16M	$-10M	$50M	$-12M	$-18M	$-12M	$28M	$-23M	$-35M	$-18M	$-78M	$-29M	$-38M	$-26M	$-7M	$-22M
Restructuring	·	·	$2M	$2M	·	·	$500.0K	$49M	·	·	$8M	$6M	$7M	$5M	$-200.0K	$1M
Operating Cash Flow	$178M	$59M	$153M	$207M	$154M	$109M	$173M	$245M	$281M	$142M	$252M	$231M	$168M	$220M	$206M	$258M
CapEx	$38M	$34M	$36M	$36M	$30M	$28M	$28M	$41M	$46M	$35M	$51M	$38M	$30M	$28M	$34M	$39M
Investing Cash Flow	$-37M	$-33M	$-40M	$-33M	$-29M	$-29M	$558M	$-40M	$-45M	$-34M	$-50M	$-37M	$-29M	$-27M	$-33M	$4M
Debt Issued	·	·	$1.04B	$68M	$0	$0	$0	$-12M	$-29M	$41M	$0	$0	$0	$0	$82M	$35M
Net Debt Issued	·	$-105M	·	·	·	$-31M	·	·	·	$-169M	·	·	·	$-270M	·	·
Financing Cash Flow	$-112M	$-107M	$700.0K	$-370M	$-7M	$-34M	$-755M	$-199M	$-197M	$-130M	$-184M	$-188M	$-196M	$-275M	$-82M	$-219M
Net Change in Cash	$28M	$-86M	$114M	$-198M	$134M	$54M	$-46M	$14M	$38M	$-28M	$27M	$-100.0K	$-58M	$-78M	$109M	$27M
Taxes Paid	$30M	$10M	$29M	$22M	$77M	$17M	$120M	$42M	$69M	$17M	$29M	$69M	$113M	$14M	$75M	$51M
Free Cash Flow	·	$25M	·	·	·	$81M	·	·	·	$107M	·	·	·	$192M	·	·
Levered FCF	·	$-8M	·	·	·	$50M	·	·	·	$59M	·	·	·	$134M	·	·

Profitabilitas 8

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	31.7%	31.7%	·	32.4%	32.9%	33.8%	·	32.9%	34.2%	34.0%	·	33.6%	33.8%	35.1%	·	35.0%
Operating Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
Net Margin	2.2%	2.7%	·	-43.8%	3.8%	4.1%	·	3.4%	5.5%	3.6%	·	6.3%	-0.42%	6.8%	·	9.0%
Pretax Margin	4.8%	3.5%	·	-42.5%	4.9%	5.4%	·	4.3%	6.7%	4.8%	·	7.9%	-0.07%	8.8%	·	11.2%
EBITDA Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
ROA	0.31%	0.36%	·	-5.8%	0.51%	0.51%	·	0.45%	0.72%	0.46%	·	0.84%	-0.06%	0.89%	·	1.3%
ROE	0.64%	0.74%	·	-12.8%	1.1%	1.1%	·	1.1%	1.8%	1.2%	·	2.2%	-0.15%	2.6%	·	3.8%
ROIC	0.61%	0.83%	·	-7.1%	0.97%	1.1%	·	0.92%	1.4%	1.0%	·	1.6%	3.7%	1.6%	·	2.1%

Likuiditas & Solvabilitas 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	1.8	1.8	·	1.5	1.0	1.1	·	1.5	1.6	1.6	·	1.6	1.6	1.6	·	1.6
Quick Ratio	1.0	1.0	·	0.9	0.6	0.7	·	0.8	1.0	0.9	·	0.9	0.9	0.9	·	1.0
Debt / Equity	0.7	0.7	·	0.7	0.7	0.7	·	0.9	0.9	1.0	·	1.1	1.2	1.2	·	1.3
LT Debt / Equity	0.7	0.7	·	0.7	0.5	0.5	·	0.8	0.9	0.9	·	1.0	1.1	1.1	·	1.3
Interest Coverage	3.1	2.3	·	-14.7	3.0	3.5	·	2.6	2.9	2.3	·	2.9	1.0	3.1	·	4.1

Efisiensi 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	1.4	1.4	·	1.4	1.4	1.3	·	1.4	1.3	1.3	·	1.3	1.3	1.3	·	1.4
Receivables Turnover	1.5	1.4	·	1.5	1.5	1.4	·	1.5	1.5	1.4	·	1.4	1.4	1.4	·	1.5

Per Saham 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$8.18	·	$8.17	$9.22	$8.95	·	$8.16	$8.00	$7.86	·	$7.54	$7.42	$7.40	·	$6.81
Revenue / Share	$2.50	$2.34	·	$2.38	$2.47	$2.32	·	$2.51	$2.49	$2.47	·	$2.54	$2.58	$2.63	·	$2.73
Cash Flow / Share	·	$0.09	·	·	·	$0.16	·	·	·	$0.21	·	·	·	$0.32	·	·
Cash / Share	·	$0.41	·	$0.37	$0.66	$0.46	·	$0.42	$0.40	$0.35	·	$0.35	$0.35	$0.44	·	$0.39
EPS (TTM)	$-0.84	$-0.81	·	$-0.13	$0.99	$1.04	·	$0.45	$0.53	$0.38	·	$0.53	$0.62	$0.91	·	$0.93

Valuasi (TTM) 10

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$6.56B	$6.55B	·	$6.58B	$6.67B	$6.69B	·	$6.82B	$6.83B	$6.87B	·	$7.04B	$7.18B	$7.34B	·	$7.62B
Net Income TTM	$-578M	$-551M	·	$-82M	$687M	$716M	·	$310M	$360M	$260M	·	$364M	$423M	$618M	·	$639M
Market Cap	·	$5.35B	·	$8.51B	$9.17B	$11.05B	·	$17.61B	$14.41B	$17.37B	·	$14.26B	$13.88B	$14.27B	·	$13.21B
Enterprise Value	·	$8.89B	·	$12.12B	$12.97B	$14.84B	·	$22.24B	$19.25B	$22.46B	·	$19.65B	$19.53B	$20.04B	·	$19.14B
P/E	-11.8	-9.7	·	-96.0	13.6	15.6	·	57.5	40.0	67.3	·	39.8	33.1	23.2	·	21.1
P/S	·	0.8	·	1.3	1.4	1.7	·	2.6	2.1	2.5	·	2.0	1.9	1.9	·	1.7
P/B	·	1.0	·	1.5	1.5	1.8	·	3.2	2.7	3.3	·	2.8	2.8	2.9	·	2.9
P / Cash Flow	·	91.2	·	·	·	101.1	·	·	·	122.6	·	·	·	65.0	·	·
EV / Revenue	·	1.4	·	1.8	1.9	2.2	·	3.3	2.8	3.3	·	2.8	2.7	2.7	·	2.5
Earnings Yield	-8.5%	-10.3%	·	-1.0%	7.4%	6.4%	·	1.7%	2.5%	1.5%	·	2.5%	3.0%	4.3%	·	4.7%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B
Margin Kotor %	32.6%	33.6%	33.9%	34.6%	33.9%
Margin Operasi %	-3.8%	16.0%	10.0%	15.0%	13.2%
Laba Bersih	$-530M	$712M	$321M	$686M	$573M
EPS Dilusian	$-0.78	$1.04	$0.47	$1.01	$0.85

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Utang / Ekuitas	0.7	0.7	1.1	1.3	1.7
Rasio Lancar	1.8	1.1	1.6	1.6	1.7
Rasio Cepat	1.0	0.6	1.0	1.0	1.1

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$495M	$692M	$724M	$710M	$842M

Pemilik institusional (13F) 493 pengaju · $7.6B total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 493

Nilai yang dipegang $7.6B

Posisi baru 97

Posisi yang keluar 60

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
97 (-7 vs Kuartal sebelumnya)	60 (-11 vs Kuartal sebelumnya)	192 (+31 vs Kuartal sebelumnya)	113 (-15 vs Kuartal sebelumnya)	+24.9M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
Dodge & Cox	$1.188.207.643	120.020.974	15,59%	Saham
VANGUARD GROUP INC	$743.810.028	64.904.889	9,76%	Saham
BlackRock, Inc.	$695.784.194	70.281.231	9,13%	Saham
VANGUARD PORTFOLIO MANAGEMENT LLC	$310.298.175	31.343.250	4,07%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$304.948.067	30.802.835	4,00%	Saham
GREENHAVEN ASSOCIATES INC	$243.909.369	24.637.310	3,20%	Saham
STATE STREET CORP	$213.572.443	21.572.974	2,80%	Saham
DIMENSIONAL FUND ADVISORS LP	$202.086.268	20.412.181	2,65%	Saham
Engine Capital Management, LP	$196.622.217	19.860.830	2,58%	Saham
BARROW HANLEY MEWHINNEY & STRAUSS LLC	$195.386.083	19.735.968	2,56%	Saham
New Mountain Capital, L.L.C.	$138.600.000	14.000.000	1,82%	Saham
Invesco Ltd.	$137.465.065	13.885.360	1,80%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$130.519.321	13.180.567	1,71%	Saham
MARSHALL WACE, LLP	$129.988.565	13.130.158	1,71%	Saham
AQR CAPITAL MANAGEMENT LLC	$115.112.902	11.627.566	1,51%	Saham
BANK OF AMERICA CORP /DE/	$108.794.506	10.989.344	1,43%	Saham
EARNEST PARTNERS LLC	$106.410.397	10.748.525	1,40%	Saham
LONDON CO OF VIRGINIA	$103.811.008	10.485.960	1,36%	Saham
FULLER & THALER ASSET MANAGEMENT, INC.	$101.537.816	10.256.345	1,33%	Saham
D. E. Shaw & Co., Inc.	$94.758.077	9.571.523	1,24%	Saham
First Pacific Advisors, LP	$81.088.326	8.190.740	1,06%	Saham
SEI INVESTMENTS CO	$78.677.367	7.947.198	1,03%	Saham
FMR LLC	$77.670.074	7.845.462	1,02%	Saham
GENDELL JEFFREY L	$75.311.973	7.607.270	0,99%	Saham
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.	$73.188.967	7.392.825	0,96%	Saham
Clarkston Capital Partners, LLC	$67.214.209	6.789.314	0,88%	Saham
MORGAN STANLEY	$66.905.804	6.758.161	0,88%	Saham
GOLDMAN SACHS GROUP INC	$61.422.976	6.204.341	0,81%	Saham
NORGES BANK	$60.307.949	6.091.712	0,79%	Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$57.627.950	5.821.005	0,76%	Saham
NORTHERN TRUST CORP	$56.753.512	5.732.678	0,74%	Saham
Freestone Grove Partners LP	$56.577.352	5.714.884	0,74%	Saham
UBS Group AG	$56.155.742	5.672.297	0,74%	Saham
AMERIPRISE FINANCIAL INC	$54.696.928	5.524.942	0,72%	Saham
YACKTMAN ASSET MANAGEMENT LP	$47.223.000	4.770.000	0,62%	Saham
SOUTHEASTERN ASSET MANAGEMENT INC/TN/	$46.782.232	4.725.478	0,61%	Saham
Brickwood Asset Management LLP	$45.515.438	4.597.519	0,60%	Saham
VANGUARD FIDUCIARY TRUST CO	$42.790.226	4.322.245	0,56%	Saham
JONES FINANCIAL COMPANIES LLLP	$42.363.659	4.120.981	0,56%	Saham
Bank of New York Mellon Corp	$40.800.098	4.121.222	0,54%	Saham
ROYCE & ASSOCIATES LP	$36.393.232	3.676.084	0,48%	Saham
FRONTIER CAPITAL MANAGEMENT CO LLC	$34.719.001	3.506.970	0,46%	Saham
PRIVATE MANAGEMENT GROUP INC	$30.662.617	3.097.234	0,40%	Saham
Voss Capital, LP	$26.235.000	2.650.000	0,34%	Saham
Prescott General Partners LLC	$25.740.000	2.600.000	0,34%	Saham
Gotham Asset Management, LLC	$24.912.796	2.516.444	0,33%	Saham
Quantinno Capital Management LP	$24.177.175	2.442.138	0,32%	Saham
KINNEY ASSET MANAGEMENT, LLC	$23.025.600	1.845.000	0,30%	Saham
Loews Corp	$21.780.000	2.200.000	0,29%	Saham
Western Standard LLC	$20.888.842	2.109.984	0,27%	Saham

Tampilkan semua 493 pemilik institusional →

Aktivis & pemilik 5%+ 1 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju	Diajukan	Kepemilikan	Status	Tujuan	Pengajuan
The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 pengajuan	7 Mei 2021	·	Pengajuan awal	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 47 orang dalam · 29 pejabat · 20 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Beli 12m	Bersih 12m
Emmanuel Ligner	President and CEO	18 Agu 2026 F	737.334	1	$993.125
Michael Stubblefield	President & CEO	21 Mei 2025 G	545.500	0	$0
Todd W. Garner	EVP and CFO	21 Sep. 2026 A	49.688	0	$0
Brent R. Jones	EVP, Chief Financial Officer	23 Feb. 2026 F	419.782	0	$0
Thomas A Szlosek	EVP & CFO	17 Mei 2023 F	77.489	0	$0
Corey Walker	President, VWR Dist. & Servs.	21 Juni 2026 F	384.535	0	$0
Mary Blenn	EVP, Chief Operating Officer	19 Feb. 2026 A	253.384	0	$0
Bjorn Hofman	EVP and COO	21 Mei 2019 A	157.143	0	$0
Brittany Hankamer	EVP, Chief HR Officer	14 Agu 2026 F	248.864	0	$0
Steven W Eck	SVP & Chief Accounting Officer	31 Juli 2026 F	129.593	0	$0
Claudius Sokenu	EVP, Chief Legal & Compliance	24 Juli 2026 F	251.228	0	$0
Ludovic Brellier	EVP, Bioscience & Medtech	1 Mei 2026 A	146.566	0	$0
Benoit Gourdier	EVP, Bioscience & Medtech	23 Feb. 2026 F	362.859	0	$0
Christophe Couturier	EVP, AMEA	8 Agu 2025 A	211.271	0	$0
James Bramwell	EVP Sales, Customer Excellence	27 Feb. 2025 S	86.605	0	$0
Kitty Sahin	EVP, Strategy&Corp Development	18 Juli 2024 F	42.274	0	$0
Randy Lee Stone	EVP, Laboratory Solutions	16 April 2024 F	68.105	0	$0
Sheri Lewis	EVP, Global Ops & Supply Chain	31 Des. 2023 F	70.692	0	$0
Frederic Vanderhaegen	EVP, Americas and Europe	25 Agu 2023 S	160.735	0	$0
Justin Miller	EVP & General Counsel	17 Mei 2023 F	93.336	0	$0
Gerard Brophy	EVP, Biopharma Production	17 Mei 2023 F	89.032	0	$0
Meghan Henson	EVP, Chief HR Officer	24 Feb. 2023 A	40.184	0	$0
Michael Wondrasch	EVP & CIO	20 Feb. 2023 F	96.072	0	$0
Mark Christopher Murray	EVP, Biomaterials & AT	13 Jan. 2022 F	18.680	0	$0
Devashish Ohri	EVP, IMEA	27 Mei 2021 M	139.095	0	$0
Sven Henrichwark	EVP, APAC Region	25 Feb. 2021 A	19.802	0	$0
Eric Mcallister	EVP, CHRO	17 Mei 2020 F	197.899	0	$0
Tanya Foxe	EVP, Operations & Supply Chain	21 Feb. 2020 A	39.458	0	$0
Ashish Kulkarni	EVP and Chief Technology Officer	21 Mei 2019 A	128.571	0	$0
Gregory T Lucier	Direktur	8 Mei 2026 P	60.000	2	$541.200
Simon Dingemans	Direktur	7 Mei 2026 A	31.495	1	$203.500
Louise Makin	Direktur	7 Mei 2026 A	47.140	0	$0
Mala Murthy	Direktur	7 Mei 2026 A	69.479	0	$0
Michael Severino	Direktur	7 Mei 2026 A	85.821	0	$0
Joseph R Massaro	Direktur	7 Mei 2026 A	77.408	0	$0
Gregory L Summe	Direktur	7 Mei 2026 A	83.381	2	$2.065.000
Sanjeev K Mehra	Direktur	7 Mei 2026 A	33.376	2	$4.882.750
John Carethers	Direktur	8 Mei 2025 A	45.858	0	$0
Lan Kang	Direktur	8 Mei 2025 A	52.315	0	$0
Juan Andres	Direktur	8 Mei 2025 A	65.480	0	$0
Jonathan M Peacock	Direktur	8 Mei 2025 A	219.815	0	$0
Christi Shaw	Direktur	11 Mei 2023 A	36.271	0	$0
Matthew S. Holt	Direktur	12 Mei 2022 A	7.908	0	$0
Rajiv Gupta	Direktur	1 April 2022 A	780.562	0	$0
Jo Natauri	Direktur	12 Juli 2021 P	557.656	0	$0
Rakesh Sachdev	Direktur	25 Feb. 2021 A	32.841	0	$0
Thomas Connolly	Direktur	18 Juni 2020 S	72.620.082	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 56 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
LSEQ · Harbor ETF Trust	2,52%	27.960 NS	31 Juli 2026	N-PORT
EPSB · Harbor ETF Trust	1,77%	6.133 NS	31 Juli 2026	N-PORT
BSJS · Invesco Exchange-Traded Self-Indexe…	1,44%	11.351.000	1 Okt. 2026	Harian
DFSV · Dimensional ETF Trust	0,52%	3.118.943 NS	31 Juli 2026	N-PORT
BKSE · BNY Mellon ETF Trust	0,40%	25.471 NS	31 Juli 2026	N-PORT
IVOV · VANGUARD ADMIRAL FUNDS	0,39%	586.296 SH	19 Agu 2026	Harian
QVMM · Invesco Exchange-Traded Fund Trust …	0,33%	88.836 SH	1 Okt. 2026	Harian
RWK · Invesco Exchange-Traded Fund Trust …	0,28%	230.747 SH	1 Okt. 2026	Harian
VFVA · VANGUARD WELLINGTON FUND	0,27%	233.604 SH	19 Agu 2026	Harian
PTMC · Pacer Funds Trust	0,27%	75.616 NS	31 Juli 2026	N-PORT
NUSC · Nushares ETF Trust	0,20%	188.520 NS	31 Juli 2026	N-PORT
MIDU · Direxion Shares ETF Trust	0,20%	10.027 NS	31 Juli 2026	N-PORT
ESML · iShares Trust	0,20%	376.218 SH	11 Sep. 2026	Harian
BBMC · J.P. Morgan Exchange-Traded Fund Tr…	0,19%	286.321 NS	31 Juli 2026	N-PORT
IVOO · VANGUARD ADMIRAL FUNDS	0,19%	1.104.592 SH	19 Agu 2026	Harian
DFAT · Dimensional ETF Trust	0,17%	1.765.932 NS	31 Juli 2026	N-PORT
DFAS · Dimensional ETF Trust	0,17%	1.854.609 NS	31 Juli 2026	N-PORT
IYH · iShares Trust	0,16%	386.410 SH	11 Sep. 2026	Harian
VBR · VANGUARD INDEX FUNDS	0,14%	9.920.672 SH	19 Agu 2026	Harian
SMMD · iShares Trust	0,14%	351.599 SH	11 Sep. 2026	Harian
FHLC · FIDELITY COVINGTON TRUST	0,13%	313.238 NS	31 Juli 2026	N-PORT
REVS · Columbia ETF Trust I	0,12%	28.653 NS	31 Juli 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,10%	1.983.361 SH	19 Agu 2026	Harian
EQAL · Invesco Exchange-Traded Fund Trust …	0,10%	50.711 SH	1 Okt. 2026	Harian
IWS · iShares Trust	0,10%	978.878 SH	11 Sep. 2026	Harian
WSML · iShares Trust	0,09%	41.659 SH	11 Sep. 2026	Harian
VXF · VANGUARD INDEX FUNDS	0,08%	7.835.858 SH	19 Agu 2026	Harian
VB · VANGUARD INDEX FUNDS	0,08%	15.636.784 SH	19 Agu 2026	Harian
TILT · FlexShares Trust	0,08%	121.976 NS	31 Juli 2026	N-PORT
RECS · Columbia ETF Trust I	0,08%	325.274 NS	31 Juli 2026	N-PORT
IWR · iShares Trust	0,07%	2.700.866 SH	11 Sep. 2026	Harian
IUS · Invesco Exchange-Traded Self-Indexe…	0,06%	37.643 SH	1 Okt. 2026	Harian
PRF · Invesco Exchange-Traded Fund Trust	0,04%	251.941 SH	1 Okt. 2026	Harian
IUSV · iShares Trust	0,03%	593.664 SH	11 Sep. 2026	Harian
DXUV · Dimensional ETF Trust	0,03%	11.452 NS	31 Juli 2026	N-PORT
IWD · iShares Trust	0,03%	1.462.438 SH	11 Sep. 2026	Harian
VONV · VANGUARD SCOTTSDALE FUNDS	0,02%	397.791 SH	19 Agu 2026	Harian
IYY · iShares Trust	0,01%	29.349 SH	11 Sep. 2026	Harian
IWB · iShares Trust	0,01%	457.613 SH	11 Sep. 2026	Harian
ITOT · iShares Trust	0,01%	885.606 SH	11 Sep. 2026	Harian
IWV · iShares Trust	0,01%	183.968 SH	11 Sep. 2026	Harian
VTI · VANGUARD INDEX FUNDS	0,01%	21.681.946 SH	19 Agu 2026	Harian
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,01%	534.809 SH	19 Agu 2026	Harian
VONE · VANGUARD SCOTTSDALE FUNDS	0,01%	109.164 SH	19 Agu 2026	Harian
VTHR · VANGUARD SCOTTSDALE FUNDS	0,01%	55.632 SH	19 Agu 2026	Harian
ESGV · VANGUARD WORLD FUND	0,01%	149.286 SH	19 Agu 2026	Harian
NEAR · iShares U.S. ETF Trust	0,01%	365.000 SH	9 Sep. 2026	Harian
DFUS · Dimensional ETF Trust	0,00%	5.257 NS	31 Juli 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	544 NS	31 Juli 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	1.476 NS	31 Juli 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	2.958 NS	31 Juli 2026	N-PORT
IJH · iShares Trust	·	23.957.709 SH	11 Sep. 2026	Harian
IJJ · iShares Trust	·	3.487.441 SH	31 Agu 2026	Harian
XJH · iShares Trust	·	93.400 SH	8 Sep. 2026	Harian
ISCB · iShares Trust	·	29.420 SH	11 Sep. 2026	Harian
ISCV · iShares Trust	·	144.718 SH	11 Sep. 2026	Harian

AVTR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 25 analis TAHAN

Target median $14.40 -6,1%

3 12,0% Beli Kuat

5 20,0% Beli

16 64,0% Tahan

1 4,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

15 analis · 2026-09-28

Target rata-rata $14.66 -4,4%

Sekarang Harga saat ini $15.34

Rendah$12.00 Rata-rata$14.66 Tinggi$19.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
AVTR	$7.82B	-14.7	-3.4%	-8.1%	-8.9%	32.6%
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
CRL	$10.02B	-70.0	-0.85%	-3.6%	-4.4%	·
TXG	$2.08B	-46.6	5.2%	-6.8%	-5.5%	69.0%
TECH	$11.03B	60.9	-0.38%	15.0%	9.0%	65.8%
RGEN	$9.23B	190.5	16.4%	6.6%	2.4%	·
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
BIO	·	·	·	·	·	·
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	·

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23

RBC Capital memberikan rating Sektor Perform untuk Avantor (AVTR) </assistant> Yahoo Finance · 4 bulan lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

AVTR Avantor, Inc. Common Stock